{"id":3106,"date":"2021-05-14T01:15:59","date_gmt":"2021-05-14T01:15:59","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=3106"},"modified":"2023-08-29T17:49:29","modified_gmt":"2023-08-29T17:49:29","slug":"pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=3106","title":{"rendered":"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458"},"content":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=PAA&amp;lang=cn\">PharmAust (ASX: PAA)<\/a>\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002<\/p>\n<p>\u8fd9\u9879\u8bd5\u9a8c\u5728\u73c0\u65af\u3001\u6089\u5c3c\u548c\u5e03\u91cc\u65af\u73ed\u7684\u4e94\u4e2a\u5730\u70b9\u8fdb\u884c\u3002<\/p>\n<p>Dr Agnew\u62e5\u670925\u5e74\u7684\u52a8\u7269\u5065\u5eb7\u7ecf\u9a8c\uff0c\u66fe\u5728\u4e1a\u52a1\u548c\u4ea7\u54c1\u5f00\u53d1\u3001\u76d1\u7ba1\u4e8b\u52a1\u3001\u4e34\u5e8a\u7814\u7a76\u3001\u6280\u672f\u652f\u6301\u548c\u836f\u7269\u534f\u540c\u8b66\u6212\u7b49\u9886\u57df\u5de5\u4f5c\u3002<\/p>\n<p>\u4ed6\u7684\u7ecf\u5386\u5305\u62ec\u5728\u5fb7\u56fd\u5236\u836f\u516c\u53f8Boehringer-Ingelheim\u5de5\u4f5c\u4e864\u5e74;\u5728Merial\u5de5\u4f5c\u4e24\u5e74;\u5e76\u5728\u7f8e\u56fdElanco\u52a8\u7269\u5065\u5eb7\u516c\u53f8\u5de5\u4f5c\u4e8618\u5e74\u3002<\/p>\n<h2>\u80bf\u7624\u7684\u7814\u7a76<\/h2>\n<p>\u5728\u4ed6\u88ab\u4efb\u547d\u4e3aPharmAust\u7684\u89d2\u8272\u540e\uff0cDr Agnew\u8868\u793a\uff0c\u4ed6\u6e34\u671b\u4e3a\u72ac\u7c7b\u80bf\u7624\u7814\u7a76\u7684\u91cd\u8981\u7cfb\u5217\u505a\u51fa\u8d21\u732e\u3002<\/p>\n<p>\u201c\u72ac\u6dcb\u5df4\u7624\u5bf9\u72d7\u548c\u4e3b\u4eba\u6765\u8bf4\u662f\u4e00\u79cd\u6bc1\u706d\u6027\u7684\u75be\u75c5\uff0c\u6211\u786e\u4fe1\uff0c\u8003\u8651\u5230\u53c2\u4e0e\u8fd9\u4e9b\u7814\u7a76\u7684\u56e2\u961f\uff0c\u5c06\u4f1a\u83b7\u5f97\u6700\u597d\u7684\u6570\u636e\u7ed3\u679c\uff0c\u201d\u4ed6\u8bf4\u3002<\/p>\n<p>PharmAust\u7684\u9996\u5e2d\u79d1\u5b66\u5b98Dr Richard Mollard\u8bf4\uff0cDr Agnew\u5c06\u662f\u5373\u5c06\u79bb\u804c\u7684\u9996\u5e2d\u7814\u7a76\u5458Dr Claire Cannon\u7684\u6709\u529b\u66ff\u4ee3\u4eba\u9009\uff0cDr Claire Cannon\u6765\u81ea\u58a8\u5c14\u672c\u5927\u5b66\u517d\u533b\u52a8\u7269\u533b\u9662\u3002<\/p>\n<p>\u201cDr Agnew\u662f\u4e00\u4e2a\u7406\u60f3\u7684\u5408\u683c\u4efb\u547d\uff0c\u6211\u4eec\u671f\u5f85\u4ece\u4ed6\u5728\u884c\u4e1a\u8bbe\u7f6e\u7684\u5e7f\u6cdb\u7ecf\u9a8c\u4e2d\u53d7\u76ca\uff0c\u201d\u4ed6\u8bf4\u3002<\/p>\n<p>\u201c\u4e0d\u5e78\u7684\u662f\uff0c\u8fd9\u4e00\u53d8\u5316\u4e5f\u610f\u5473\u7740\u58a8\u5c14\u672c\u8bd5\u9a8c\u7ad9\u70b9\u5c06\u505c\u6b62\u62db\u8058(\u4f46\u5c06)\u5728\u5176\u4ed6\u7ad9\u70b9\u7ee7\u7eed\u62db\u8058\uff0c\u6211\u4eec\u9884\u8ba1\u4ea4\u4ed8\u7684\u603b\u4f53\u65f6\u95f4\u4e0d\u4f1a\u53d1\u751f\u53d8\u5316\u3002\u201d<\/p>\n<h2>\u7ec6\u80de\u514b\u9686\u6269\u589e<\/h2>\n<p>\u72ac\u6dcb\u5df4\u7624\u662f\u4e00\u79cd\u7531B\u6216t\u6dcb\u5df4\u7ec6\u80de\u514d\u75ab\u8868\u578b\u4e0d\u53d7\u63a7\u5236\u548c\u75c5\u7406\u6027\u514b\u9686\u6027\u6269\u589e\u5f15\u8d77\u7684\u75be\u75c5\u3002<\/p>\n<p>\u5b83\u6700\u5e38\u7d2f\u53ca\u6709\u7ec4\u7ec7\u7684\u539f\u53d1\u6027\u548c\u7ee7\u53d1\u6027\u6dcb\u5df4\u7ec4\u7ec7\uff0c\u5305\u62ec\u9aa8\u9ad3\u3001\u80f8\u817a\u3001\u6dcb\u5df4\u7ed3\u548c\u813e\u810f\u3002<\/p>\n<p>1\u6708\uff0cPharmAust<a href=\"http:\/\/smallcaps-production.test\/pharmaust-begins-next-trial-monepantel-treat-canines-lymphoma\/?lang=cn\">\u5f00\u59cb\u4e86monepantel\u7247\u5242\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684IIb\u671f\u8bd5\u9a8c<\/a>\uff0c\u968f\u540e\u7684IIa\u671f\u7814\u7a76\u663e\u793a\u8be5\u836f\u7269\u53ef\u80fd\u5bfc\u81f4\u80bf\u7624\u6d88\u9000\u548c\u75be\u75c5\u7a33\u5b9a\u3002<\/p>\n<p>\u4e0a\u4e2a\u6708\uff0c<a href=\"http:\/\/smallcaps-production.test\/pharmaust-progress-lead-drug-monepantel-treating-canine-human-cancers-covid-19\/?lang=cn\">6\u53ea\u60a3\u67094 &#8211; 5\u671fb\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac<\/a>\u7684IIb\u4e2d\u671f\u7ed3\u679c\u63d0\u4f9b\u4e86\u652f\u6301\u6027\u8bc1\u636e\uff0c\u8bc1\u660emonepantel\u8840\u6d46\u5904\u4e8e\u6291\u5236\u764c\u75c7\u751f\u957f\u6240\u9700\u7684\u6c34\u5e73\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002 \u8fd9\u9879\u8bd5\u9a8c\u5728\u73c0\u65af\u3001\u6089\u5c3c\u548c\u5e03\u91cc\u65af\u73ed\u7684\u4e94\u4e2a\u5730\u70b9\u8fdb\u884c\u3002 Dr Agnew\u62e5\u670925\u5e74\u7684\u52a8\u7269\u5065\u5eb7\u7ecf\u9a8c\uff0c\u66fe\u5728\u4e1a\u52a1\u548c\u4ea7\u54c1\u5f00\u53d1\u3001\u76d1\u7ba1\u4e8b\u52a1\u3001\u4e34\u5e8a\u7814\u7a76\u3001\u6280\u672f\u652f\u6301\u548c\u836f\u7269\u534f\u540c\u8b66\u6212\u7b49\u9886\u57df\u5de5\u4f5c\u3002 \u4ed6\u7684\u7ecf\u5386\u5305\u62ec\u5728\u5fb7\u56fd\u5236\u836f\u516c\u53f8Boehringer-Ingelheim\u5de5\u4f5c\u4e864\u5e74;\u5728Merial\u5de5\u4f5c\u4e24\u5e74;\u5e76\u5728\u7f8e\u56fdElanco\u52a8\u7269\u5065\u5eb7\u516c\u53f8\u5de5\u4f5c\u4e8618\u5e74\u3002 \u80bf\u7624\u7684\u7814\u7a76 \u5728\u4ed6\u88ab\u4efb\u547d\u4e3aPharmAust\u7684\u89d2\u8272\u540e\uff0cDr Agnew\u8868\u793a\uff0c\u4ed6\u6e34\u671b\u4e3a\u72ac\u7c7b\u80bf\u7624\u7814\u7a76\u7684\u91cd\u8981\u7cfb\u5217\u505a\u51fa\u8d21\u732e\u3002 \u201c\u72ac\u6dcb\u5df4\u7624\u5bf9\u72d7\u548c\u4e3b\u4eba\u6765\u8bf4\u662f\u4e00\u79cd\u6bc1\u706d\u6027\u7684\u75be\u75c5\uff0c\u6211\u786e\u4fe1\uff0c\u8003\u8651\u5230\u53c2\u4e0e\u8fd9\u4e9b\u7814\u7a76\u7684\u56e2\u961f\uff0c\u5c06\u4f1a\u83b7\u5f97\u6700\u597d\u7684\u6570\u636e\u7ed3\u679c\uff0c\u201d\u4ed6\u8bf4\u3002 PharmAust\u7684\u9996\u5e2d\u79d1\u5b66\u5b98Dr Richard Mollard\u8bf4\uff0cDr Agnew\u5c06\u662f\u5373\u5c06\u79bb\u804c\u7684\u9996\u5e2d\u7814\u7a76\u5458Dr Claire Cannon\u7684\u6709\u529b\u66ff\u4ee3\u4eba\u9009\uff0cDr Claire Cannon\u6765\u81ea\u58a8\u5c14\u672c\u5927\u5b66\u517d\u533b\u52a8\u7269\u533b\u9662\u3002 \u201cDr Agnew\u662f\u4e00\u4e2a\u7406\u60f3\u7684\u5408\u683c\u4efb\u547d\uff0c\u6211\u4eec\u671f\u5f85\u4ece\u4ed6\u5728\u884c\u4e1a\u8bbe\u7f6e\u7684\u5e7f\u6cdb\u7ecf\u9a8c\u4e2d\u53d7\u76ca\uff0c\u201d\u4ed6\u8bf4\u3002 \u201c\u4e0d\u5e78\u7684\u662f\uff0c\u8fd9\u4e00\u53d8\u5316\u4e5f\u610f\u5473\u7740\u58a8\u5c14\u672c\u8bd5\u9a8c\u7ad9\u70b9\u5c06\u505c\u6b62\u62db\u8058(\u4f46\u5c06)\u5728\u5176\u4ed6\u7ad9\u70b9\u7ee7\u7eed\u62db\u8058\uff0c\u6211\u4eec\u9884\u8ba1\u4ea4\u4ed8\u7684\u603b\u4f53\u65f6\u95f4\u4e0d\u4f1a\u53d1\u751f\u53d8\u5316\u3002\u201d \u7ec6\u80de\u514b\u9686\u6269\u589e \u72ac\u6dcb\u5df4\u7624\u662f\u4e00\u79cd\u7531B\u6216t\u6dcb\u5df4\u7ec6\u80de\u514d\u75ab\u8868\u578b\u4e0d\u53d7\u63a7\u5236\u548c\u75c5\u7406\u6027\u514b\u9686\u6027\u6269\u589e\u5f15\u8d77\u7684\u75be\u75c5\u3002 \u5b83\u6700\u5e38\u7d2f\u53ca\u6709\u7ec4\u7ec7\u7684\u539f\u53d1\u6027\u548c\u7ee7\u53d1\u6027\u6dcb\u5df4\u7ec4\u7ec7\uff0c\u5305\u62ec\u9aa8\u9ad3\u3001\u80f8\u817a\u3001\u6dcb\u5df4\u7ed3\u548c\u813e\u810f\u3002 1\u6708\uff0cPharmAust\u5f00\u59cb\u4e86monepantel\u7247\u5242\u6cbb\u7597\u72ac\u6dcb\u5df4\u7624\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u968f\u540e\u7684IIa\u671f\u7814\u7a76\u663e\u793a\u8be5\u836f\u7269\u53ef\u80fd\u5bfc\u81f4\u80bf\u7624\u6d88\u9000\u548c\u75be\u75c5\u7a33\u5b9a\u3002 \u4e0a\u4e2a\u6708\uff0c6\u53ea\u60a3\u67094 &#8211; 5\u671fb\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u7684IIb\u4e2d\u671f\u7ed3\u679c\u63d0\u4f9b\u4e86\u652f\u6301\u6027\u8bc1\u636e\uff0c\u8bc1\u660emonepantel\u8840\u6d46\u5904\u4e8e\u6291\u5236\u764c\u75c7\u751f\u957f\u6240\u9700\u7684\u6c34\u5e73\u3002<\/p>\n","protected":false},"author":4,"featured_media":11705,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[241],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458<\/title>\n<meta name=\"description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458\" \/>\n<meta property=\"og:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-14T01:15:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:49:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/PharmAust-ASX-PAA-new-lead-researcher-phase-IIb-monepantel-trial-canine-lymphoma-Dr-Kim-Agnew.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458\" \/>\n<meta name=\"twitter:description\" content=\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/\",\"name\":\"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-05-14T01:15:59+00:00\",\"dateModified\":\"2023-08-29T17:49:29+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458","description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458","og_description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/","og_site_name":"smallcapsCN","article_published_time":"2021-05-14T01:15:59+00:00","article_modified_time":"2023-08-29T17:49:29+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/PharmAust-ASX-PAA-new-lead-researcher-phase-IIb-monepantel-trial-canine-lymphoma-Dr-Kim-Agnew.jpg","type":"image\/jpeg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458","twitter_description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/","url":"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/","name":"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-05-14T01:15:59+00:00","dateModified":"2023-08-29T17:49:29+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u4e34\u5e8a\u9636\u6bb5\u80bf\u7624\u5b66\u516c\u53f8PharmAust (ASX: PAA)\u4efb\u547dDr Kim Agnew\u4e3a\u5176IIb\u671f\u517d\u533b\u4e34\u5e8a\u8bd5\u9a8c\u7684\u65b0\u9996\u5e2d\u7814\u7a76\u5458\uff0c\u8be5\u8bd5\u9a8c\u5c06\u6297\u764c\u836f\u7269monepantel\u7528\u4e8etreatment-na\u00efve b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u5ba0\u7269\u72d7\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-new-lead-researcher-phase-iib-monepantel-trial-canine-lymphoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"PharmAust\u4e3a\u72ac\u6dcb\u5df4\u7624IIb\u671fmonepantel\u8bd5\u9a8c\u83b7\u5f97\u65b0\u7684\u9996\u5e2d\u7814\u7a76\u5458"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3106"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3106"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3106\/revisions"}],"predecessor-version":[{"id":11704,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/3106\/revisions\/11704"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/11705"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}